Stay updated on 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.

Latest updates to the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page
- Check3 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check10 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision marker changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page for the study record shows a 403 Forbidden error instead of the study details, indicating access restrictions to the entry.SummaryDifference19%

- Check59 days agoChange DetectedRevision marker updated from v3.6.5 to v3.6.6. This represents a minor system update to the page, not a modification to study content or visible information.SummaryDifference0.1%

- Check66 days agoChange DetectedPublications section added with author names and a PubMed-cited study citation, plus a note that publications are drawn from PubMed.SummaryDifference0.3%

Stay in the know with updates to 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.